This site is secured using RapidSSL

Aggressive cancers in ‘evolutionary arms race’ with the immune system

Published on 19 January 2020  | Download | back to previous


This is an image from this news item. (click to view the video)Aggressive and highly-mutated cancers are engaged in an “evolutionary arms race” with the immune system, new research suggests.

Gullet and stomach cancers with faults in their systems for repairing DNA build up huge numbers of genetic mutations which make them resistant to treatments like chemotherapy.

But these numerous mutations mean they appear foreign to the immune system, leaving them vulnerable to attack, and susceptible to new immunotherapies.

Scientists at the Institute of Cancer Research, London (ICR), found that these “hyper-mutant” tumours rapidly evolve strategies to disguise themselves from the immune system and evade attack.

They hope that in the future, the findings could help optimise treatment with immunotherapy, and other drugs such as chemotherapy.

Click here to continue reading this article sourced from Sciencefocus.com

An image from our site
Digestive Cancers Europe vzw/asbl
Terrestlaan 30
3090 Overijse
Belgium
The information contained in this website is for general health education purposes only. Its objective is to give general guidance, and should not replace or be interpreted as a consultation with a physician or a healthcare professional. For any personal questions about your health, please talk to your doctor. Even if we try to keep the information on our website up-to-date and correct, we cannot guarantee that it covers all the latest medical and scientific insights.
Warning!!! Warning!!! Cookies are disabled Warning!!! Warning!!!